Publicaciones en las que colabora con José Alberto Orfao de Matos Correia e Vale (52)

2023

  1. Clinical, Histopathologic and Genetic Features of Rhabdoid Meningiomas

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  2. Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice

    Cancer research, Vol. 82, Núm. 6, pp. 1098-1109

2021

  1. Genomic heterogeneity of pancreatic ductal adenocarcinoma and its clinical impact

    Cancers, Vol. 13, Núm. 17

  2. Genomic profiling of sporadic liver metastatic colorectal cancer

    Seminars in Cancer Biology, Vol. 71, pp. 98-108

  3. The Second Oncogenic Hit Determines the Cell Fate of ETV6-RUNX1 Positive Leukemia

    Frontiers in Cell and Developmental Biology, Vol. 9

  4. Tracking the antibody immunome in sporadic colorectal cancer by using antigen self-assembled protein arrays

    Cancers, Vol. 13, Núm. 11

  5. Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome

    Brain Pathology, Vol. 31, Núm. 2, pp. 365-380

2020

  1. Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients

    Cancer Drug Resistance, Vol. 3, Núm. 1, pp. 83-97

  2. Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Distribution of subsets of blood monocytic cells throughout life

    Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 1, pp. 320-323.e6

  2. Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients

    Oncotarget, Vol. 9, Núm. 35, pp. 24081-24096

  2. Lmo2 expression defines tumor cell identity during T-cell leukemogenesis

    EMBO Journal, Vol. 37, Núm. 14

  3. Loss of Pax5 exploits sca1-BCR-ABLp190 susceptibility to confer the metabolic shift essential for pB-ALL

    Cancer Research, Vol. 78, Núm. 10, pp. 2669-2679

  4. Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

    Blood cancer journal, Vol. 8, Núm. 12, pp. 117

  5. Spatio-temporal tumor heterogeneity in metastatic CRC tumors: A mutational-based approach

    Oncotarget, Vol. 9, Núm. 76, pp. 34279-34288

2017

  1. Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors

    Oncotarget, Vol. 8, Núm. 64, pp. 107685-107700

2016

  1. Genomic characterization of liver metastases from colorectal cancer patients

    Oncotarget, Vol. 7, Núm. 45, pp. 72908-72922

  2. Tumor infiltrating immune cells in gliomas and meningiomas

    Brain, Behavior, and Immunity, Vol. 53, pp. 1-15